Wei‐Jie Fang

725 total citations
42 papers, 566 citations indexed

About

Wei‐Jie Fang is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Wei‐Jie Fang has authored 42 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Biomedical Engineering. Recurrent topics in Wei‐Jie Fang's work include Protein purification and stability (25 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Wei‐Jie Fang is often cited by papers focused on Protein purification and stability (25 papers), Viral Infectious Diseases and Gene Expression in Insects (12 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). Wei‐Jie Fang collaborates with scholars based in China, United States and Singapore. Wei‐Jie Fang's co-authors include Jianwen Jiang, Liling Zhang, Rahul G Ingle, Jane V. Aldrich, Huidi Jiang, Zhonglin Luo, Thomas F. Murray, Yanjun Cui, John F. Carpenter and T. V. Yakovleva and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and The Journal of Physical Chemistry C.

In The Last Decade

Wei‐Jie Fang

38 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Jie Fang China 11 251 168 119 99 59 42 566
Kaizhu Zeng China 12 95 0.4× 149 0.9× 102 0.9× 127 1.3× 9 0.2× 14 522
Peng Shu China 15 107 0.4× 50 0.3× 57 0.5× 458 4.6× 22 0.4× 46 752
Wen United States 11 78 0.3× 60 0.4× 69 0.6× 230 2.3× 12 0.2× 133 575
Charles Linder Israel 18 250 1.0× 87 0.5× 339 2.8× 99 1.0× 16 0.3× 42 912
Daniel J. Lundberg United States 13 169 0.7× 26 0.2× 80 0.7× 98 1.0× 27 0.5× 23 531
Na Zheng China 14 129 0.5× 52 0.3× 60 0.5× 158 1.6× 8 0.1× 49 529
Lingwei Meng China 16 288 1.1× 29 0.2× 113 0.9× 80 0.8× 13 0.2× 28 654
Sun Yong Lee South Korea 14 481 1.9× 191 1.1× 55 0.5× 229 2.3× 9 0.2× 35 985
Peiyao Zhu China 17 136 0.5× 32 0.2× 125 1.1× 178 1.8× 7 0.1× 37 677
Yulin Sun China 17 74 0.3× 41 0.2× 46 0.4× 130 1.3× 4 0.1× 26 769

Countries citing papers authored by Wei‐Jie Fang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Jie Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jie Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jie Fang more than expected).

Fields of papers citing papers by Wei‐Jie Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Jie Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jie Fang. The network helps show where Wei‐Jie Fang may publish in the future.

Co-authorship network of co-authors of Wei‐Jie Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Jie Fang. A scholar is included among the top collaborators of Wei‐Jie Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Jie Fang. Wei‐Jie Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Wei, et al.. (2025). An overview of needle-free injection technology in human vaccines. International Journal of Pharmaceutics. 685. 126287–126287.
3.
Wang, Haibin, et al.. (2025). A Novel Peptide Mapping Method Utilizing Cysteine as a Reducing Agent. Pharmaceutical Research. 42(1). 173–184. 3 indexed citations
4.
Ingle, Rahul G, et al.. (2024). Histidine as a versatile excipient in the protein-based biopharmaceutical formulations. International Journal of Pharmaceutics. 662. 124472–124472. 10 indexed citations
5.
Liu, Jian-Zhong, et al.. (2024). An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates. Pharmaceutical Research. 41(12). 2299–2317. 2 indexed citations
6.
Huang, Qiong, et al.. (2024). The Effects of Excipients on Freeze-dried Monoclonal Antibody Formulation Degradation and Sub-Visible Particle Formation during Shaking. Pharmaceutical Research. 41(2). 321–334. 1 indexed citations
7.
Ingle, Rahul G & Wei‐Jie Fang. (2023). An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics. Pharmaceutics. 15(4). 1158–1158. 31 indexed citations
8.
Gao, Han, et al.. (2023). Monitoring of low-molecular-weight protein aggregation by CE-SDS as a complementary method to SE-HPLC. Journal of Pharmaceutical and Biomedical Analysis. 234. 115521–115521. 1 indexed citations
9.
Shen, Bin-Bin, et al.. (2022). Characterization of Grinding-Induced Subvisible Particles and Free Radicals in a Freeze-Dried Monoclonal Antibody Formulation. Pharmaceutical Research. 39(2). 399–410. 3 indexed citations
10.
Fang, Wei‐Jie, et al.. (2022). Freeze-Dried Monoclonal Antibody Formulations are Unexpectedly More Prone to Degradation Than Liquid Formulations Under Shaking Stress. Journal of Pharmaceutical Sciences. 111(7). 2134–2138. 6 indexed citations
11.
12.
Fang, Wei‐Jie, et al.. (2021). Effects of Secondary Package on Freeze-Dried Biopharmaceutical Formulation Stability During Dropping. Journal of Pharmaceutical Sciences. 110(8). 2916–2924. 3 indexed citations
13.
Ingle, Rahul G & Wei‐Jie Fang. (2021). Prefilled dual chamber devices (DCDs) – Promising high-quality and convenient drug delivery system. International Journal of Pharmaceutics. 597. 120314–120314. 6 indexed citations
14.
Fang, Wei‐Jie, et al.. (2020). Protein Sub-Visible Particle and Free Radical formation of a Freeze-Dried Monoclonal Antibody Formulation During Dropping. Journal of Pharmaceutical Sciences. 110(4). 1625–1634. 7 indexed citations
15.
Shen, Bin-Bin, Zhongwei Zhang, Junjie Yuan, et al.. (2020). Formation of an Unprecedented Impurity during CE-SDS Analysis of a Recombinant Protein. Pharmaceutical Research. 37(11). 228–228. 8 indexed citations
16.
Yuan, Junjie, Dong Gao, Fengping Hu, et al.. (2020). Isolation and characterization of charge variants of infliximab biosimilar HS626. Journal of Chromatography B. 1162. 122485–122485. 5 indexed citations
17.
Wang, Guanqi, Xinyu Wang, Jianqing Gao, et al.. (2020). Formation of protein sub-visible particles during powder grinding of a monoclonal antibody. European Journal of Pharmaceutics and Biopharmaceutics. 149. 1–11. 7 indexed citations
18.
Shen, Bin-Bin, et al.. (2019). Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions. Pharmaceutical Research. 36(8). 118–118. 4 indexed citations
19.
Wang, Haibin, Zhao Wang, Hua Bai, et al.. (2014). Formation of protein sub-visible particles during vacuum degassing of etanercept solutions. International Journal of Biological Macromolecules. 66. 151–157. 8 indexed citations
20.
Zhang, Liling, Wei‐Jie Fang, & Jianwen Jiang. (2011). Effects of Residual Solvent on Membrane Structure and Gas Permeation in a Polymer of Intrinsic Microporosity: Insight from Atomistic Simulation. The Journal of Physical Chemistry C. 115(22). 11233–11239. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kaizhu Zeng Breakdown of academic impact, for papers by Peng Shu Breakdown of academic impact, for papers by Wen Breakdown of academic impact, for papers by Charles Linder Breakdown of academic impact, for papers by Daniel J. Lundberg Breakdown of academic impact, for papers by Na Zheng Breakdown of academic impact, for papers by Lingwei Meng Breakdown of academic impact, for papers by Sun Yong Lee Breakdown of academic impact, for papers by Peiyao Zhu Breakdown of academic impact, for papers by Yulin Sun
Rankless by CCL
2026